Leiden, the Netherlands, July 17, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary…
^
Original-Research: Pharming Group NV - from First Berlin Equity Research
GmbH
03.04.2025 / 17:08 CET/CEST
Dissemination of a Research,…
^Original-Research: Pharming Group NV - from First Berlin Equity ResearchGmbH03.04.2025 / 17:08 CET/CESTDissemination of a Research, transmitted by EQS News…
Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the…
Leiden, the Netherlands, March 13, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents…
Leiden, the Netherlands, February 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in…
^Original-Research: Pharming Group NV - from First Berlin Equity ResearchGmbH29.10.2024 / 14:51 CET/CESTDissemination of a Research, transmitted by EQS News…
^
Original-Research: Pharming Group NV - from First Berlin Equity Research
GmbH
29.10.2024 / 14:51 CET/CEST
Dissemination of a Research,…
Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…
Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate…
^
Original-Research: Pharming Group NV - from First Berlin Equity Research
GmbH
26.08.2024 / 15:55 CET/CEST
Dissemination of a Research,…
^Original-Research: Pharming Group NV - from First Berlin Equity ResearchGmbH26.08.2024 / 15:55 CET/CESTDissemination of a Research, transmitted by EQS News…
Leiden, the Netherlands, August 1, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its preliminary…
Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…
…
…
Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…
Pharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than average. The latest…
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY…
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY…
Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces…
Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces…
…
…
Leiden, The Netherlands, March 14, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents…
Leiden, The Netherlands, February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary…
^
Original-Research: Pharming Group NV - von First Berlin Equity Research GmbH
Einstufung von First Berlin Equity Research…
^
Original-Research: Pharming - von First Berlin Equity Research GmbH
Einstufung von First Berlin Equity Research GmbH zu…